DCP and AFP-L3 risk biomarkers for HCC
Aliases:
This biomarker is also known as:- DCP and AFP-L3 risk biomarkers for HCC (Panel)
- DCP and AFP-L3 risk biomarkers for HCC
Description…
DCP and AFP-L3 panel for the detection of hepatocellular carcinoma (HCC). DCP (des-gamma carboxy-prothrombin) and AFP-L3 (lectin-bound alpha-fetoprotein) as a panel for detection of HCC.
Datasets
There are no datasets associated with this biomarker.
Attributes
| QA State: | Curated |
|---|---|
| HGNC Name: |
Panel Details
The following organs have data associated with this biomarker…
Attributes
| Phase: | 3 |
|---|---|
| QA State: | Curated |
Organ-specific information for this biomarker is currently being annotated or is "under review".
Logging in may give you privileges to view additional information.
Contact the
Informatics Center
if you believe you should have access to this biomarker.
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.